共 65 条
- [1] Allinson JP, 2023, LANCET, V401, P1183, DOI 10.1016/S0140-6736(23)00131-9
- [2] [Anonymous], 2004, FDA approves new drug for hypoparathyroidism, a rare disorder 2024
- [3] AstraZeneca, Beyfortus Approved in the EU for the Prevention of RSV Lower Respiratory Tract Disease in Infants 2022
- [4] Binks MJ, 2020, LANCET CHILD ADOLESC, V4, P425, DOI 10.1016/S2352-4642(20)30090-0
- [7] Business Wire, MHRA grants approval of Beyfortus (nirsevimab) for prevention of RSV disease in infants
- [8] cebm, Wanting a particular reference category in categorical risk data